Perspectives of stem cell therapy in Duchenne muscular dystrophy (Q27013613)

Duchenne muscular dystrophy

GOA release 2020-03-11

1 reference

Mirella Meregalli

1

0 references

Yvan Torrente

object named as

Yvan Torrente

8

0 references

author name string

Andrea Farini

2

1 reference

Marzia Belicchi

3

1 reference

Daniele Parolini

4

1 reference

Letizia Cassinelli

5

1 reference

Paola Razini

6

1 reference

Clementina Sitzia

7

1 reference

language of work or name

1 reference

September 2013

1 reference

1 reference

280

1 reference

PubMed

issue

17

1 reference

PubMed

page(s)

4251-62

1 reference

Muscle regeneration by bone marrow-derived myogenic progenitors

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Myoblasts in pattern formation and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

The molecular regulation of myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

21 January 2018

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Expression of full-length utrophin prevents muscular dystrophy in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Induced dystrophin exon skipping in human muscle explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Advances in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Skeletal muscle stem cell birth and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Muscle stem cells in development, regeneration, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Direct isolation of satellite cells for skeletal muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Self-renewal and expansion of single transplanted muscle stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Stem cell based therapies to treat muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

The fate of individual myoblasts after transplantation into muscles of DMD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Long-term self-renewal of postnatal muscle-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Muscle-derived stem cells: characterization and potential for cell-mediated therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Stem and progenitor cells in skeletal muscle development, maintenance, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Heterogeneity of embryonic and adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal stem cells: isolation and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal stem cells: progress toward promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mobilization of endothelial progenitor cells into the circulation in burned patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Importance of the SDF-1:CXCR4 axis in myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Cord blood in regenerative medicine: do we need immune suppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Cellular and molecular regulation of muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Myogenic specification of side population cells in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Vascular pericytes express osteogenic potential in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12083